Hematologic Malignancies Testing Market Competitive Landscape, Research Methodology, Business Opportunities, Statistics and Industry Analysis Report by 2027
According to the
current analysis by Emergen Research, the Global Hematologic Malignancies
Testing Market size is expected to reach USD 5.45 Billion in terms
of revenue from USD 1.95 Billion in 2019, delivering a CAGR of 14.6% through
2027
The Hematologic Malignancies Testing market forecasts
included in the report are performed by our team of experts and are of great
significance as they provide deep insights into various crucial industry
parameters. These facts and figures help readers evaluate the global market
growth, production, and consumption rates, volatility in demand and product
prices, and upcoming market trends over the projected period
To get leading
market solutions, visit the link below:
https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market
A
SWOT analysis is performed on the leading companies engaged in the Hematologic
Malignancies Testing market to offer a better understanding of the strengths, opportunities,
weaknesses, and threats of the leading companies. It also covers production and
consumption rate, the volatility of prices and demands, market share, market
size, global position, and market position of each player
Key
players in the global hematologic malignancies testing market are ArcherDx,
Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Invitae Corporation,
Abbott Laboratories, NeoGenomics Laboratories, Inc., Cancer Genetics Inc.,
Asuragen, Inc., Invivoscribe, Inc., and Adaptive Biotechnologies Corporation,
among others.
Key
Highlights From Report
In March 2020, Sysmex
Corporation, a leading diagnostic solutions company, received Japan marketing
clearance for the world's largest genome research organization, BGI Group’s coronavirus
kit distribution. This initiative strengthened the company’s position in
Japan.
Emergen Research
has segmented the Global Hematologic Malignancies Testing Market on the basis
of product, technology, disease, end-use, and region:
·
Regional Outlook (Revenue, USD Billion; 2017-2027)
o
North America
1.
U.S.
2.
Canada
3.
Mexico
o
Europe
1.
Germany
2.
U.K.
3.
France
4.
BENELUX
5.
Rest of Europe
o
Asia Pacific
1.
China
2.
Japan
3.
South Korea
4.
India
5.
Rest of APAC
o
Latin America
1.
Brazil
2.
Rest of LATAM
o
Middle East & Africa
1.
Saudi Arabia
2.
U.A.E.
3.
Rest of MEA
Contact Us:
Corporate Sales Specialist
Emergen
Research | Web: www.emergenresearch.com
Direct
Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Comments
Post a Comment